Randomized phase II study of concurrent gefitinib and chemotherapy versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer (NSCLC) with sensitive <i>EGFR</i> mutations: NEJ005/TCOG0902.

  • Satoshi Oizumi
    First Department of Medicine, Hokkaido University School of Medicine, Sapporo, Japan
  • Shunichi Sugawara
    Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan
  • Koichi Minato
    Department of Respiratory Medicine, Gunma Prefectural Cancer Center, Gunma, Japan
  • Toshiyuki Harada
    Center for Respiratory Diseases, Hokkaido Social Insurance Hospital, Sapporo, Japan
  • Akira Inoue
    Department of Respiratory Medicine, Tohoku University Hospital, Sendai, Japan
  • Yuka Fujita
    Department of Respiratory Medicine, National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan
  • Makoto Maemondo
    Department of Respiratory Medicine, Miyagi Cancer Center, Natori, Japan
  • Hirohisa Yoshizawa
    Bioscience Medical Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan
  • Kazuhiko Ito
    Department of Respiratory Medicine, Niigata City General Hospital, Niigata, Japan
  • Akihiko Gemma
    Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan
  • Masaru Nishitsuji
    Department of Respiratory Medicine, Ishikawa Prefectural Central Hospital, Kanazawa, Japan
  • Masao Harada
    Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan
  • Hiroshi Isobe
    Department of Medical Oncology, KKR Sapporo Medical Center, Sapporo, Japan
  • Ichiro Kinoshita
    Department of Medical Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  • Satoshi Morita
    Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • Kunihiko Kobayashi
    Department of Respiratory Medicine, Saitama Medical University International Medical Center, Saitama, Japan
  • Koichi Hagiwara
    Department of Respiratory Medicine, Saitama Medical University, Saitama, Japan
  • Minoru Kurihara
    The Tokyo Cooperative Oncology Group, Tokyo, Japan
  • Toshihiro Nukiwa
    South Miyagi Medical Center, Sendai, Japan

収録刊行物

  • Journal of Clinical Oncology

    Journal of Clinical Oncology 32 (15_suppl), 8016-8016, 2014-05-20

    American Society of Clinical Oncology (ASCO)

被引用文献 (1)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ